Näky sermorelin review
By Ray Kaminski, who covers specialty pharmacy pricing and compounding economics.
Updated September 2026.
Not a partner — this company pays us nothing, and it is listed anyway.
“Starting at $185/mo ($195/mo for month-to-month plan)” — the rare page that prints the floor and the standing rate in the same sentence, so you can see the gap without hunting for it.
We are paid nothing if you sign up here.What that figure actually is
Näky prints $195, per month. On this site that is a standing rate — the distinction the board draws a different mark for, and the reason a figure here never appears on its own.
- The figure
- $195
- What kind of figure
- a standing rate
- Billing cycle
- per month
- What it buys
- weekly injection; dose not stated
- What the seller says is included
- Nothing itemised beside the figure on the page we read.
- Read on
- September 2026
- Read from
- https://benaky.com/products/sermorelin
What else the page states
- Dose
- Not stated on the page we read. A subscription with no dose on it is half a price.
- How it is taken
- injection
- States served
- Not available in all states (its own wording)
- Insurance, HSA and FSA
- The page we read says nothing about insurance, HSA or FSA.
- Pharmacy named for sermorelin
- None. No compounder is named on any sermorelin page we read. A pharmacy named on this company’s GLP-1 pages would not count here — it says nothing about who makes this drug.
- FDA action
- We have not established one. That is not the same as saying none exists: we match on a company’s domain and address rather than on a brand name, and no screen has been recorded against this company.
- Where the link goes
- Straight to this company’s own sermorelin page.
What Näky discloses, scored
Scroll the table sideways for the remaining columns.
| What is scored | Earned | Out of | What the page shows |
|---|---|---|---|
| What kind of figure it publishes | 40 | 40 | $195, a standing rate the seller will charge again |
| States the billing cycle | 15 | 15 | “per month”, in the seller’s own words |
| States the dose the price buys | 0 | 15 | no dose on the page we read |
| Itemises what the price includes | 0 | 10 | nothing itemised beside the figure |
| Names a pharmacy on a sermorelin page | 0 | 10 | no compounder named on any sermorelin page we read |
| States the states it serves | 5 | 5 | Not available in all states (its own wording) |
| Leaves no unlabelled figure on the page | 5 | 5 | every figure on the page carries what it is |
| Total | 65 | 100 | Higher means more of the price is on the page before you hand over an email address. |
Every line is computed from the fields on this page and summed; nothing is judged by hand. The score measures what the seller publishes, not whether it is cheap or whether the drug works.
Where Näky sits
On the full board it is row 21 of 89. That board is ordered by what each seller states about its own figure and by nothing else — payment changes neither the price we publish nor where a row sits. Its disclosure score of 65 out of 100 is what orders the boards below, none of which is ordered by price.
- Sermorelin providers that publish a standing monthly rate
- Sermorelin providers that name the states they serve
Prices move. Everything above was read on September 2026 and is republished with that date attached; check the seller’s own page before you buy.